Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

The Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional) is a federally funded research opportunity administered by the National Institutes of Health under the U.S. Department of Health and Human Services. Specifically, it is managed through the National Institute on Minority Health and Health Disparities, which focuses on advancing scientific research to improve health outcomes and reduce disparities among underserved populations. This initiative reflects a targeted federal effort to address persistent inequities in cancer incidence and mortality affecting American Indian and Alaska Native populations, particularly those residing in rural and underserved communities. The primary purpose of this funding opportunity is to support comprehensive, multidisciplinary research that addresses cancer prevention, diagnosis, and treatment for American Indian and Alaska Native populations. The program emphasizes generating actionable findings that can directly improve clinical outcomes and quality of life for patients and their families. Research supported under this initiative is expected to examine disparities in cancer incidence and mortality and develop interventions or models that can be translated into practice within affected communities. Funding for this opportunity is delivered through a cooperative agreement mechanism, indicating substantial involvement from the funding agency during the project period. The total estimated program funding is three million dollars, with one anticipated award. While specific award ceilings and floors are not provided, the funding is intended to support a large-scale, coordinated research project that may include clinical trials, although such trials are optional. There is no cost sharing or matching requirement associated with this opportunity, which reduces the financial burden on applicants and broadens accessibility for eligible institutions. Eligibility for this opportunity includes a defined set of institutional applicants. Eligible entities consist of nonprofits with or without 501(c)(3) status, public and private institutions of higher education, and state-controlled academic institutions. The opportunity is designated as a limited competition, meaning that only selected or invited organizations may submit applications. This restriction typically reflects a strategic approach to funding where the agency identifies specific organizations or research groups with the capacity to conduct the proposed work. The application process follows standard NIH procedures and includes submission through designated federal systems. Applications will undergo a rigorous peer-review process in accordance with NIH guidelines, where proposals are evaluated based on scientific merit, relevance to program objectives, and potential impact. Only applications deemed meritorious through this review process will be considered for funding. While specific application components are not detailed in the forecast, NIH applications generally require research plans, budgets, biosketches, and institutional documentation. The timeline for this opportunity is currently in the forecast stage. The estimated posting date is November 25, 2026, with an anticipated application deadline of January 25, 2027. Awards are expected to be made by September 30, 2027, with the project start date aligned to the same day. As a forecasted opportunity, applicants are encouraged to begin preparing in advance, particularly given the limited competition structure. Questions or inquiries can be directed to the NIMHD DCHPS Scientific Team via the provided email contact. This opportunity does not explicitly indicate recurrence, suggesting it may be a one-time or irregular funding initiative tied to strategic priorities.